Vimarsana
Biggest News Aggregation in the World

Page 18 - Nature Structural News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nature Structural. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nature Structural Today - Breaking & Trending Today

University of Illinois: Atomic structure of antifungal drug confirms unusual mechanism, opens door to less-toxic derivatives - Vimarsana News

University of Illinois: Atomic structure of antifungal drug confirms unusual mechanism, opens door to less-toxic derivatives

Advanced molecular imaging technology has now mapped the structure of a drug widely used to treat fungal infections but whose workings have mystified researchers and physicians for nearly 70 years.In a new study, researchers at the University of Illi

Gallery of human RNA polymerases - Vimarsana News

Gallery of human RNA polymerases

EMBL researchers’ continued work with RNA polymerases provides fundamental information to understand enzyme mutations connected to rare diseases and

Atomic structure of antifungal drug confirms unusual mechanism, opens door to less-toxic derivatives - Vimarsana News

Atomic structure of antifungal drug confirms unusual mechanism, opens door to less-toxic derivatives

Illinois chemistry professor Martin Burke co-led a team that mapped the unusual aggregate structure of the antifungal drug amphotericin B

Biologists discover how a protein in our body works - Vimarsana News

Biologists discover how a protein in our body works

It's an old needlework trick, and a protein in our body knows it: Instead of threading yarn into the eye from the end, it can be easier to pass a loop through it.

The FDA will soon decide on Merck's COVID-19 pill. Here are what experts say are the pros and cons - Vimarsana News

The FDA will soon decide on Merck's COVID-19 pill. Here are what experts say are the pros and cons

A team of infectious disease advisers will soon look at the results of Merck's clinical trial and decide whether to recommend emergency use authorization for the first pill to treat early-stage COVID-19.

Source: wmtw.com